Skip Page Header

Home > Items where Subject is "G Health and disease > Substance use disorder > Drug use disorder > Drug withdrawal syndrome"

Up a level
Export as
Group by: Item Type | No Grouping
Number of items at this level: 19.

Article

Pahl, Adrienne and Young, Leslie and Buus-Frank, Madge E and Marcellus, Leonora and Soll, Roger (2020) Non‐pharmacological care for opioid withdrawal in newborns. Non‐pharmacological care for opioid withdrawal in newborns , 12 .

Bahji, Anees and Stephenson, Callum and Tyo, Richard and Hawken, Emily R and Seitz, Dallas P (2020) Prevalence of cannabis withdrawal symptoms among people with regular or dependent use of cannabinoids: a systematic review and meta-analysis. JAMA Network Open , 3 , (4 e202370) , e202370.

Rahimi-Movaghar, Afarin and Gholami, Jaleh and Amato, Laura and Hoseinie, Leila and Yousefi-Nooraie, Reza and Amin-Esmaeili, Masoumeh (2018) Pharmacological therapies for management of opium withdrawal. Cochrane Database of Systematic Reviews , (6) .

Burch, Jane and Magalhães, Pedro V (2017) Clinical question: How does buprenorphine compare with methadone or adrenergic agonists in people undergoing opioid withdrawal? Cochrane Clinical Answers .

Burch, Jane and Magalhães, Pedro V (2017) Clinical question: How do alpha2‐adrenergic agonists compare with placebo or methadone for management of opioid withdrawal? Cochrane Clinical Answers .

Gowing, Linda and Ali, Robert and White, Jason M (2017) Opioid antagonists with minimal sedation for opioid withdrawal. Cochrane Database of Systematic Reviews , (6) .

Van Hout, Marie Claire and Hearne, Evelyn (2017) User experiences of development of dependence on the synthetic cannabinoids, 5f-AKB48 and 5F-PB-22, and subsequent withdrawal syndromes. International Journal of Mental Health and Addiction , 15 , (3) , pp. 565-579.

Gowing, Linda and Farrell, Michael and Ali, Robert and White, Jason M (2016) Alpha2-adrenergic agonists for the management of opioid withdrawal. Cochrane Database of Systematic Reviews , (5) .

Davies, Mark (2015) Clinical question: What are the benefits and harms of naloxone in opiate‐exposed newborn infants? Cochrane Clinical Answers .

Amato, Laura and Davoli, Marina and Minozzi, Silvia and Ferroni, Eliana and Ali, Robert and Ferri, Marica (2013) Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database of Systematic Reviews , (2) .

Gowing, Linda and Ali, Robert and White, Jason M (2010) Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal. Cochrane Database of Systematic Reviews , (1) .

News

[Medical Independent] 40 babies admitted for drug withdrawal treatment. (08 Feb 2018)

[thejournal.ie] , Halpin, Hayley 92 babies suffering from drug withdrawal recorded in Irish hospitals last year. (12 Jul 2017)

Report

Kenny, Pauline and Swan, Amy and Berends, Lynda and Jenner, Linda and Hunter, Barbara and Mugavin, Janette (2009) Alcohol and other drug withdrawal: practice guidelines. Victoria: Turning Point Alcohol and Drug Centre.

Copeland, Jan and Frewen, Amie and Elkins, Kathryn (2009) Management of cannabis use disorder and related issues. A clinician’s guide. Sydney: National Cannabis Prevention and Information Centre, University of New Wales.

Mental Health and Drug and Alcohol Office. (2008) Nursing & midwifery clinical guidelines - identifying & responding to drug & alcohol issues. Sydney: New South Wales Department of Health.

Mental Health and Drug and Alcohol Office. (2008) Drug and alcohol withdrawal clinical practice guidelines - NSW. Sydney: NSW Department of Health.

National Medicines Information Centre. (2002) Report to the National Advisory Committee on Drugs on "use of lofexidine in the management of opiate dependence syndrome". Dublin: Stationery Office.

Dail Debates

[Oireachtas] Joint Oireachtas Committee on Health and Children - babies born to mothers with substance abuse issues: discussion. (24 Sep 2015)

This list was generated on Thu May 13 04:02:42 2021 IST.